Y-mAbs Announces Data To Be Presented At SIOP 2021
Y-mAbs Therapeutics, Inc. (("Y-mAbs", NASDAQ:YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment